The Technical AnalystExchange: EURONEXT Sector: Healthcare Industry: Medical Care Facilities
Raffles Medical Group Ltd Price, Forecast, Insider, Ratings, Fundamentals & Signals
-0.97% SGD1.020
America/New_York / 17 mai 2024 @ 05:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1 894.47 mill |
| EPS: | 0.0500 |
| P/E: | 20.40 |
| Earnings Date: | Jul 28, 2024 |
| SharesOutstanding: | 1 857.32 mill |
| Avg Daily Volume: | 1.760 mill |
| RATING 2024-05-17 |
|---|
| A+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Neutral | |
| P/E: | Buy | |
| Price To Book: | Neutral |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | n/a | n/a | ||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.19x |
| Company: PE 20.40 | sector: PE 17.08 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.68x |
| Company: PE 20.40 | industry: PE 30.09 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
SGD1.723 (68.94%) SGD0.703 |
| Date: 2024-05-19 |
| Expected Trading Range (DAY) |
|---|
|
SGD 1.000 - 1.040 ( +/- 1.96%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | SGD1.020 (-0.97% ) |
| Volume | 3.33 mill |
| Avg. Vol. | 1.760 mill |
| % of Avg. Vol | 189.03 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BSL.SI
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BSL.SI
Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services. The company also offers emergency services, family medicine services, health screening, and various multi-disciplinary specialist clinic services. In addition, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; provides advisory and consultancy services, and develops IT solutions; and engages in research and experimental development on biotechnology, and life and medical science. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore.